Manuscripts
Showing 1556 manuscripts.
Predictors of AIDS-related morbidity and mortality in a southern U.S. cohort
Citation
Michael J. Mugavero, Brian Wells Pence, Kathryn Whetten, Jane Leserman, Marvin Swartz, Dalene Stangl, Nathan Thielman. Predictors of AIDS-related morbidity and mortality in a southern U.S. cohort. AIDS Patient Care and STDs. 2007. 21: 681-90. PMID: 17919095Year
2007
Journal
AIDS Patient Care and STDs
Multifunctional human immunodeficiency virus (HIV) gag-specific CD8+ T-cell responses in rectal mucosa and peripheral blood mononuclear cells during chronic HIV type 1 infection
Citation
J. William Critchfield, Donna Lemongello, Digna H. Walker, Juan C. Garcia, David M. Asmuth, Richard B. Pollard, B. L. Shacklett. Multifunctional human immunodeficiency virus (HIV) gag-specific CD8+ T-cell responses in rectal mucosa and peripheral blood mononuclear cells during chronic HIV type 1 infection. Virology. 2007. 81: 5460-5471.Year
2007
Journal
Virology
The virologic, immunologic, and clinical effects of interleukin 2 with potent antiretroviral therapy in patients with moderately advanced human immunodeficiency virus infection: a randomized controlled clinical trial- AIDS Clinical Trials Group 328
Citation
Pablo Tebas, Anne-Marie Duliege, Ronald T. Mitsuyasu, Richard B. Pollard, Rebecca S. Gelman, Richard B. Pollard, Deborah Weng-Cherng, Alan Landay, John L. Fahey, Richard C. Reichman, Alejo Erice, R. Pat Bucy, J. Michael Kilby, Michael M. Lederman, Carol S. Dukes-Hamilton, Juan J.L. Lertora, Becky Stephenson. The virologic, immunologic, and clinical effects of interleukin 2 with potent antiretroviral therapy in patients with moderately advanced human immunodeficiency virus infection: a randomized controlled clinical trial- AIDS Clinical Trials Group 328. Archives of Internal Medicine. 2007. 167: 597-605. PMID: 17389292Year
2007
Journal
Archives of Internal Medicine
Factors associated with early study discontinuation in AACTG studies, DACS 200
Citation
Janet Andersen, Robert J. Fass, Charles van der Horst. Factors associated with early study discontinuation in AACTG studies, DACS 200. Contemporary Clinical Trials. 2007. 28: 583-92.Year
2007
Journal
Contemporary Clinical Trials
The prevalence and incidence of neurocognitive impairment in the HAART era
Citation
Kevin R. Robertson, Marlene Smurzynski, Thomas D. Parsons, Kunling Wu, Ronald J. Bosch, Julia (Wei) Wu, Justin C. McArthur, Ann C. Collier, Scott Evans, Ronald J. Ellis. The prevalence and incidence of neurocognitive impairment in the HAART era. AIDS. 2007. 21: 1915-21.Year
2007
Journal
AIDS
Pharmacokinetic evaluation of the effects of ribavirin on zidovudine triphosphate formation: ACTG 5092s study team
Citation
Francesca Aweeka, Minhee Kang, Ji Young Yu, Patricia S. Lizak, Beverly L. Alston-Smith, Raymond T. Chung. Pharmacokinetic evaluation of the effects of ribavirin on zidovudine triphosphate formation: ACTG 5092s study team. HIV Medicine. 2007. 8: 288-94.Year
2007
Journal
HIV Medicine
Virologic response to potent antiretroviral therapy and modeling of HIV dynamics in early pediatric infection.
Citation
Paul Palumbo, Hulin Wu, Ellen Gould Chadwick, Ping Ruan, Katherine Luzuriaga, John H. Rodman, Ram Yogev. Virologic response to potent antiretroviral therapy and modeling of HIV dynamics in early pediatric infection.. Journal of Infectious Diseases. 2007. 196: 23-29. PMID: 17538879Year
2007
Journal
Journal of Infectious Diseases
Intracellular pharmacokinetics of once versus twice daily zidovudine and lamivudine in adolescents.
Citation
Patricia M. Flynn, John H. Rodman, Jane C. Lindsey, Brian Robbins, Edmund Capparelli, Katherine M. Knapp, Jose F. Rodriguez, James McNamara, Leslie Serchuck, Barbara E. Heckman, Jaime Martinez. Intracellular pharmacokinetics of once versus twice daily zidovudine and lamivudine in adolescents.. Antimicrobial Agents and Chemotherapy. 2007. 51: 3516-3522. PMID: 17664328Year
2007
Journal
Antimicrobial Agents and Chemotherapy
Study
P1012
Population pharmacokinetics of lamivudine in human immunodeficiency virus-exposed and -infected infants.
Citation
Adriana H. Tremoulet, Edmund Capparelli, Pratima K. Patel, Edward P. Acosta, Katherine Luzuriaga, Yvonne J. Bryson, Diane W. Wara, Diane Holland, Mark Mirochnick. Population pharmacokinetics of lamivudine in human immunodeficiency virus-exposed and -infected infants.. Antimicrobial Agents and Chemotherapy. 2007. 51: 4297 - 7302. PMID: 17893155Year
2007
Journal
Antimicrobial Agents and Chemotherapy
CYP2B6 genetic variants impact the pharmacokinetics of nevirapine and clinical response in HIV-1 infected children receiving HAART.
Citation
Akihiko Saitoh, Elizabeth Sarles, Edmund Capparelli, Francesca Aweeka, Andrea Kovacs, Sandra K. Burchett, Andrew A. Wiznia, Sharon Appelbaum Nachman, Terence Fenton, Stephen A. Spector. CYP2B6 genetic variants impact the pharmacokinetics of nevirapine and clinical response in HIV-1 infected children receiving HAART.. AIDS. 2007. 21: 2191 - 2199. PMID: 18090046Year
2007
Journal
AIDS